Navigation Links
Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
Date:12/15/2008

NAPA, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced an agreement with the Institute of Bioorganic Chemistry of the Polish Academy of Sciences in Poznan, Poland for the exclusive rights to a new and promising tumor treatment using an RNAi based therapeutic technology for the potential use against a broad range of cancers.

This technology, which specifically targets a novel cancer biomarker, was developed by the Institute in cooperation with Department of Neurosurgery and Neurotraumatology University of Medical Sciences in Poznan, Poland. Under the terms of the collaborative agreement, Senetek will have rights for all applications of the in-licensed technologies in exchange for undisclosed royalty payments to be paid to the Institute upon commercialization.

Frank Massino, CEO and Chairman of Senetek, commented, "We are extremely pleased that our relationship with the Institute of Bioorganic Chemistry of the Polish Academy of Sciences has resulted in another important addition to our technology portfolio. We look forward to the opportunities that lie ahead with this novel advancement in RNAi therapy."

About Senetek PLC

Senetek PLC (OTCBB: SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The Company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of the best-selling anti-aging product sold in the North American physician market. For more in
'/>"/>

SOURCE Senetek PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Senetek Affirms Strong Financial Position
2. Senetek PLC Reports Second Quarter 2008 Financial Results
3. Senetek PLC Reports First Quarter 2008 Financial Results
4. Senetek PLC Announces Appointments of Key Personnel
5. Senetek PLC in Dispute With Marketer of Pyratine-6(TM)
6. Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP)
7. t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application
8. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
9. Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
10. Affitech Acquires Pharmexas Diabody Technology
11. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Research and Markets ( ... "Biopreservation Market by Product, Biospecimen, Application and ... report to their offering. The global ... Million by 2020 from USD 2,150.48 Million in ... 2015 and 2020. Biopreservation ensures the ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... the BioBot 1, at the 2015 TERMIS World Congress in Boston. The launch ... biomedical engineering institutions around the world. The printer is revolutionary for its compact ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... of product safety and pharmacovigilance services and software tools to pharmaceutical and life ... Mobile by Allergan Japan. PRIMO Mobile is a mobile data intake solution that ...
(Date:9/3/2015)... ... ... The latest addition to the Mettler-Toledo PCE portfolio is the newly ... pharmaceutical and healthcare industry can use the LSS to print track-and-trace labels for their ... can be fully integrated into the production line and is also available as a ...
Breaking Biology Technology:Global Biopreservation Market 2015-2020 - Product, Biospecimen, Application and End User Analysis of the $3.73 Billion Industry 2Global Biopreservation Market 2015-2020 - Product, Biospecimen, Application and End User Analysis of the $3.73 Billion Industry 3BioBots to Debut Desktop 3D Bioprinter for Living Tissue at TERMIS Global Tissue Engineering Conference in Boston 2BioBots to Debut Desktop 3D Bioprinter for Living Tissue at TERMIS Global Tissue Engineering Conference in Boston 3BioBots to Debut Desktop 3D Bioprinter for Living Tissue at TERMIS Global Tissue Engineering Conference in Boston 4November Research Group’s PRIMO Mobile Goes Live at Allergan Japan 2Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3
... , NEW YORK, Dec. 4 Stemline Therapeutics, Inc. today ... SL-401 and SL-501, in both in vitro and animal ... poster presentation at the upcoming 51st Annual Meeting of the American ... December 5-8, 2009. The poster will be presented by Stemline,s collaborators ...
... 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, today announced that it ... FDG-PET clinical trial of VIA-2291. , The FDG-PET trial ... in the US and Canada including Massachusetts General Hospital, Mount ...
... , NEW DELHI, ... Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke ... November 22, 2009. Beike is China,s leading,stem cell research and regenerative ... the Indian Podiatry Association (IPA), aimed,to help podiatrists and researchers with ...
Cached Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
(Date:9/2/2015)... 2015 About hand geometry biometrics Security ... organizations, telecommunication and hospitals as well as for individuals ... numeric keypads are used to prevent unauthorised access. Hand ... fingers of an individual, width of the fingers, and ... light and reflectors can be used for capturing the ...
(Date:9/2/2015)... 2015 Security of data and assets ... government organizations, telecommunications, hospitals, as well as individuals. ... being used to prevent unauthorised access. Technological advancements ... individuals could gain access to secure premises after ... hardware devices and numeric codes. However, hackers also ...
(Date:9/2/2015)... Biometric technology ... system which uses identical human characteristic such as ... and finger print. Increasing number of terror attacks ... which provides high level of security. Traditional security ... are vulnerable to attacks. Furthermore, Biometric technology uses ...
Breaking Biology News(10 mins):Global Hand Geometry Biometrics Market 2015-2019 2Global Hand Geometry Biometrics Market 2015-2019 3Global Biometrics Spending Market in the Government Sector 2015-2019 2Global Biometrics Spending Market in the Government Sector 2015-2019 3Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 2Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 3Biometrics Technology Market is Expected to Reach $13.8 Billion by 2015: Hexa Research Inc. 4
... on the growth and yield of horticultural crops; studies ... the world,s irrigated land unsuitable for crop production. Imbalances ... mineral deficiencies, and drastic physiological and biochemical changes in ... their water usageto conserve water, some plants close their ...
... researchers report that the brains of tiny spiders are so ... their legs. As part of ongoing research to understand how ... nervous systems of nine species of spiders, from rainforest giants ... the spiders get smaller, their brains get proportionally bigger, filling ...
... 2011)Regular exercise has proven benefits in preventing and ... tough to meet the American Diabetes Association guidelines of ... A new study, conducted by researchers at McMaster University, ... a small proof-of-principle study in eight type 2 diabetes ...
Cached Biology News:Salt-tolerant crops show higher capacity for carbon fixation 2A whole new meaning for thinking on your feet 2Exercising harder -- and shorter -- can help Type 2 diabetes 2Exercising harder -- and shorter -- can help Type 2 diabetes 3
...
RNase-Free DNase 50 l...
... polymerase is a DNA-dependent RNA polymerase which ... It efficiently synthesizes in vitro transcripts ... stream from a T7 promoter. Transcripts ... for in vitro translation, substrates in RNA ...
... Klenow fragment is a ... coli DNA Polymerase I ... -> 5 exonuclease activity, but ... activity. Klenow retains the polymerization ...
Biology Products: